Erectile Dysfunction After Surgical Treatment of Lung Cancer: Real-World Evidence

Sexual problems are common in male lung cancer survivors. However, the development of erectile dysfunction (ED) in lung cancer patients after surgery has been rarely explored. In this study, we aimed to explore the incidence and risk factors of ED after lung cancer surgery. From 2000 to 2012, 6025 a...

Full description

Saved in:
Bibliographic Details
Published in:Clinical epidemiology 2020-01, Vol.12, p.977-987
Main Authors: Hung, Ming-Szu, Chen, Yi-Chuan, Huang, Tsung-Yu, Ho, Dong-Ru, Lee, Chuan-Pin, Chen, Pau-Chung, Yang, Yao-Hsu
Format: Article
Language:English
Subjects:
Age
Anxiety
Arthritis
Asthma
Cancer research
Cancer therapies
Cardiovascular disease
Care and treatment
Chronic obstructive pulmonary disease
Clinical medicine
Comorbidity
Comparative analysis
Diabetes
Emergency medical services
Epidemiology
Erectile dysfunction
Hypertension
Impotence
Kidney diseases
Lung cancer
Original Research
Ostomy
Patients
Quality of life
Respiratory system agents
Risk factors
Surgery
Urbanization
Weight control
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sexual problems are common in male lung cancer survivors. However, the development of erectile dysfunction (ED) in lung cancer patients after surgery has been rarely explored. In this study, we aimed to explore the incidence and risk factors of ED after lung cancer surgery. From 2000 to 2012, 6025 and 24,100 male patients were included in each matched cohort of lung cancer and non-lung cancer patients, respectively. Poisson regression analysis was used to calculate the incidence rate ratio (IRR) and 95% confidence interval (CI). The incidence of ED was higher in the lung cancer cohort compared to the non-lung cancer cohort (38.47 vs 28.28 per 10,000 person-years) with an adjusted IRR (aIRR) of 1.34 (95% CI: 1.06-1.70, =0.014) after the confounders were adjusted for. An increased incidence of ED was observed in the lung cancer cohort aged 40-54 years (aIRR: 5.44, 95% CI: 2.25-13.15,
ISSN:1179-1349
1179-1349
DOI:10.2147/CLEP.S264439